The Dividend ETF Built for Whatever the Market Does Next This exchange-traded fund (ETF) is built to last, invested in scores of healthy dividend payers.
Skip XRP and Buy This Top Cryptocurrency Instead If history is any guide, investors should be buying Ethereum, not XRP, right now.
How Residential Property Investment Services Spot Growth Areas Buying a home for income can feel exciting. However, it can also feel scary. You may wonder where prices will rise. You may also ask where renters want to
Jensen Huang Used 1 Word to Describe AI Demand. It Could Be the Most Important of 2026. Nvidia's CEO is clearly bullish, describing an environment that should keep rewarding the chipmaker.
Luxury Wall Art: Transforming Modern Homes into Timeless Masterpieces A beautifully designed home is more than furniture, lighting, and décor—it is an expression of personality, taste, and lifestyle. Among all interior design
Time to Diversify Internationally? It’s a deep dive into the Hidden Gems Investing mailbag with questions about international diversification, stocks that have lost momentum, and the changing cybersecurity landscape.
Lam Research CEO Sees AI Fueling $140 Billion Chip Equipment Boom Lam Research (
NASDAQ:LRCX ) President and CEO Tim Archer said AI demand is reshaping the semiconductor equipment market across logic, memory, storage and packaging, creating what Bernstein analyst Stacy Rasgon described as a “renaissance” for wafer fab equipment.
Speaking at a Bernstein conference,
Datadog Share Value Has More Than Doubled As Investors Recognize a Growing Market Opportunity Datadog crossed $1 billion in quarterly revenue for the first time and raised its full-year outlook, driven by AI-related demand.
The 1 Metric That Tells Me This Tech Stock Is About to Rip Higher -- and It Just Flashed Data center capex is set to accelerate this year, and that's great news for Micron Technology investors.
3 Stocks to Buy With Less Than $20 There is a lot to like about these companies beyond their approachable share prices.
Thriving in the Age of Overwhelm Why do so many people feel overwhelmed right now? And what can investors do about it?
Why This Fund Dumped $35 Million of UiPath Even as Revenue Grew 17% UiPath delivers automation software and AI-driven solutions to streamline enterprise workflows across major global industries.
2 High-Yield Vanguard ETFs That Have Taken in More Than $2 Billion in 2026 Even though tech remains the market's dominant theme, high-yield equity ETFs are still attracting significant investor money.
What to Know About This New $83 Million Virtu Financial Position Virtu Financial delivers technology-driven trading and liquidity solutions across global markets for institutional clients.
Pitney Bowes CEO Sells Company Shares Worth $3.8 Million. What Does That Mean for Investors? This technology-driven logistics provider disclosed notable insider selling following a year of strong total returns and shifting ownership.
RXO Stock Has Surged 75% Since This Fund Made a $10 Million Bet RXO uses a digital freight marketplace to deliver asset-light logistics and transportation solutions across multiple U.S. industries.
Give Your Family the Gift of an Estate Plan Learn how to protect yourself, your loved ones, and your assets with an updated estate plan.
SpaceX IPO Nears and Retail Makes a Comeback Learn how much money SpaceX is (or isn’t) making from rocket launches and AI in anticipation of the company’s upcoming IPO.
Stop Trying to Beat the Market: This Vanguard ETF Outperforms 90% of Professional Fund Managers High fees make it nearly impossible for money managers to beat the S&P 500 in the long term. Why not just buy the index and be done with it?
Why One Real Estate Fund Dumped $62 Million of Cousins Properties Stock This office-focused REIT manages Class A properties in high-growth Sun Belt markets, serving corporate tenants seeking premium space.
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.
What to Know About This Fund's $74.8 Million Indivior Sale Indivior develops buprenorphine-based treatments for opioid dependence, serving markets in the US, UK, and worldwide.
NASA And UFO ETFs Are Surging Ahead Of SpaceX IPO But Key Risks Remain Top space ETFs like NASA and UFO have surged and are seeing strong inflows this year ahead of the SpaceX IPO but risks remain.
This Wealth Advisor Just Reduced a Maturing Bond Fund. Here's How Target-Maturity ETFs Actually Work. This ETF targets investment grade corporate bonds maturing in 2026, aiming to deliver predictable income and a defined maturity date.
3 Space Stocks Flying Under the Radar and Worth Buying This Month As the space industry rockets upward, a few companies shouldn't be left behind by investors.
Why Wall Street Is Dead Wrong About This Popular Stock Often, investors and Wall Street analysts focus on the short term and don't give enough thought to the long term.
These Artificial Intelligence (AI) Stocks Have Crushed Nvidia in 2026 With Gains of 67% and 121%. They Can Still Soar Higher Lumentum Holdings and Applied Materials are important players in the AI infrastructure space, which explains why their stock prices have been soaring this year.
Bloom Energy vs. Plug Power: Which Hydrogen Stock Is a Better Buy in 2026? Between Bloom Energy and Plug Power, one company is generating positive cash flows and growing its revenue at a torrid pace.
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200% Indivior develops buprenorphine-based therapies for opioid dependence, serving healthcare providers and treatment centers worldwide.
Tom Lee's BitMine Stock At Risk As Ethereum ETF Outflows Jump, Network Stats Fall Tom Lee's BitMine Immersion Technologies (
NYSE:BMNR ) stock has crashed to a crucial support level, and the ongoing Ethereum performance suggests that it may
Why This Fund Made a $30 Million Bet on Floor & Decor Amid a 30% Stock Drop Floor & Decor supplies hard surface flooring and installation products to professional installers and DIY customers across the U.S.
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
